Development of a novel orally active inverse agonist of estrogen-related receptor gamma (ERRγ), KH-NDTC as an enhancer for sodium iodide symporter: Its pharmacological effects in anaplastic thyroid cancer (ATC) in vitro and in vivo

Saved in:
Bibliographic Details
Published inDrug metabolism and pharmacokinetics Vol. 34; no. 1; p. S34
Main Authors Jeon, Yong Hyun, Choi, Seon Hee, Kim, Sang Kyoon
Format Journal Article
LanguageEnglish
Published Elsevier Ltd 01.01.2019
Online AccessGet full text

Cover

More Information
ISSN:1347-4367
1880-0920
DOI:10.1016/j.dmpk.2018.09.128